LadRx Corp Files Q1 2025 10-Q
Ticker: LADX · Form: 10-Q · Filed: May 14, 2025 · CIK: 799698
| Field | Detail |
|---|---|
| Company | Ladrx Corp (LADX) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech
Related Tickers: LADX
TL;DR
LadRx Corp 10-Q filed. Q1 2025 financials out. Check it.
AI Summary
LadRx Corp filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Cytrx Corp, is in the biological products sector. Financial details for the first quarter of 2025 and comparative periods are presented, including common stock, additional paid-in capital, and retained earnings.
Why It Matters
This filing provides investors with an update on LadRx Corp's financial position and performance for the first quarter of 2025, crucial for understanding the company's ongoing operations and potential.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags or significant new information presented.
Key Numbers
- Q1 2025 — Reporting Period (First quarter financial results)
- 2025-03-31 — As of Date (End of the reporting period)
- 2025-05-14 — Filing Date (Date the report was submitted to the SEC)
Key Players & Entities
- LadRx Corp (company) — Filer of the 10-Q
- Cytrx Corp (company) — Former name of LadRx Corp
- 20250331 (date) — End of the reporting period
- 20250514 (date) — Filing date
- 0000799698 (company) — Central Index Key for LadRx Corp
FAQ
What were the key financial metrics for LadRx Corp in Q1 2025?
The filing provides data for common stock, additional paid-in capital, and retained earnings as of March 31, 2025, and comparative periods, but specific income statement figures are not detailed in this excerpt.
When was LadRx Corp formerly known as?
LadRx Corp was formerly known as Cytrx Corp, with a name change date of 19920703.
What is LadRx Corp's Standard Industrial Classification?
LadRx Corp's SIC code is 2836, categorized under BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
What is the business address of LadRx Corp?
The business address for LadRx Corp is 11726 SAN VICENTE BOULEVARD, SUITE 650, LOS ANGELES, CA 90049.
What is the fiscal year end for LadRx Corp?
LadRx Corp's fiscal year ends on December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding LadRx Corp (LADX).